-
Most Recent
Search Results
240 results for cannabis
Although the Future Is Appealing, Don’t Buy ACB Stock Just Yet
Production capacity ramp-up is way ahead of demand growth. Margin compression, high investment in R&D and sales will impact positive cash flow possibility.
Why Aphria Stock Is Suffering From the Cannabis 2.0 Letdown
Despite the fact that APHA has posted two straight profitable quarters, Aphria stock has been hit hard this week as Cannabis 2.0 stumbles.
No Major Bullish Triggers for Aphria Stock
Growth in core business remains slow. Medicinal cannabis market will expand at a low pace and that will impact overall growth.
America’s 2020 Election Is a Win-Win for Canopy Growth Stock
CGC stock investors may think they need a Democrat to win the 2020 election. However, the identity of the Democratic nominee may be much more…
Aurora Stock: Making the Right Moves, but Long Road to Cash Flows
Aurora Cannabis stock is attractive with regional growth, R&D investment and focus on high-margin products. Free cash flow still not in sight.
Cannabis Stocks Are Gaining, but We’re Still Bearish
The rise in cannabis stocks is a much-needed reprieve for pot bulls. But unfortunately, we don’t think it’s going to last.
Marijuana News: Teva Pharmaceuticals Industries Ltd (ADR) Signs Cannabis Inhaler Deal
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) has some good marijuana news for those living in Israel that want to inhale the drug.
Cannabis Stocks Surge as Biden Moves to Reclassify Marijuana ASAP
Cannabis stocks are flying this afternoon on news that Biden, the Department of Justice and the DEA are moving to reclassify marijuana.
Canopy Growth Stock Investors Should Focus On The Forest, Not The Trees
Canopy Growth’s a leader in a secular growth market with huge potential. That means CGC stock could ultimately turn into a multi-bagger for investors.
3 Cannabis Stocks to Buy Before They Explode Higher
Support for cannabis legalization reached all-time highs in 2023, creating a long list of cannabis stocks to buy today.
3 Underperforming Cannabis Stocks You Better Not Be Buying
The cannabis sector as a whole has potential and positive catalysts. Still, there are some expensive cannabis stocks to sell at this point.
4 Reasons to Buy Cronos Stock On the Vaping Dip
CRON stock is down more than 50% on concerns about slowing cannabis growth in Canada and vaping-related health concerns. However, there are plenty of reasons…
Prepare for Cannabis’ Second Act and Hold Your Aphria Shares
Solid financing and the implementation of Cannabis 2.0 will drive Aphria’s growth in 2020’s first half.
Why HEXO Stock Is Interesting, But Not Compelling
HEXO stock is interesting, but it’s not a compelling investment because HEXO probably won;t become a major player in the cannabis space.
Aurora Cannabis Stock Is the Bitcoin of Equity Markets
Aurora Cannabis has a large addressable market globally. However, inventory build-up is a near-term concern, and growth in the medicinal segment needs to be watched.
3 Interesting Catalysts Will Boost Aurora Cannabis Stock
ACB stock has fallen 32%in the last month, creating a good entry point. Aurora Cannabis stock has multiple, positive catalysts.
Is November the Time to Buy Aurora Cannabis Stock?
Unless ACB stock’s sales growth translates into profits, there is likely to be little upside potential in the share price.
Tilray Stock’s Quarter Will Be Seriously Judged, Like Its Rivals
The market’s weighing Tilray stock like it weighs most better-developed publicly traded companies.
7 – 10 of 240 results
